Detalhe da pesquisa
1.
The feasibility of existing JADAS10 cut-off values in clinical practice: a study of data from The Finnish Rheumatology Quality Register.
Pediatr Rheumatol Online J
; 21(1): 35, 2023 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37060076
2.
Infliximab treatment in patients with rheumatoid arthritis and spondyloarthropathies in clinical practice: adverse events and other reasons for discontinuation of treatment.
Scand J Rheumatol
; 37(1): 6-12, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18189188
3.
Effects of infliximab on cytokines, myeloperoxidase, and soluble adhesion molecules in patients with juvenile idiopathic arthritis.
Scand J Rheumatol
; 36(3): 189-93, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17657672